Tig Advisors, LLC Intra Cellular Therapies, Inc. Transaction History
Tig Advisors, LLC
- $1.38 Billion
- Q2 2024
A detailed history of Tig Advisors, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Tig Advisors, LLC holds 50,500 shares of ITCI stock, worth $3.7 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
50,500Holding current value
$3.7 Million% of portfolio
0.34%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
400Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$704 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$463 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$273 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$252 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$220 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.92B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...